Stem Point Capital LP Portfolio Holdings

Stem Point Capital LP

  • $334 Billion
  • Q3 2024

Stem Point Capital LP has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $334 Billion distributed in 58 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Syndax Pharmaceuticals Inc with a value of $33.3B, Roivant Sciences Ltd. with a value of $32B, Merus N.V. with a value of $21B, Immunovant, Inc. with a value of $19.1B, and Arcutis Biotherapeutics, Inc. with a value of $16.5B.

Examining the 13F form we can see an decrease of $6.26B in the current position value, from $340B to 334B.

Stem Point Capital LP is based out at New York, NY

Below you can find more details about Stem Point Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $334 Billion
Healthcare: $277 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$910M
$33.3 Billion 9.98% of portfolio
1,731,191
Q3 2024 Added 22.59%
$8.83B
$32 Billion 9.57% of portfolio
2,769,819
Q3 2024 Added 2.1%
$2.09B
$21 Billion 6.3% of portfolio
421,222
Q3 2024 Added 45.92%
$3.55B
$19.1 Billion 5.73% of portfolio
671,001
Q3 2024 Reduced 33.69%
$610M
$16.5 Billion 4.95% of portfolio
1,778,318
Q3 2024 Added 84.21%
$2.71B
$15.8 Billion 4.74% of portfolio
1,481,809
Q3 2024 Reduced 0.89%
$125B
$14.2 Billion 4.26% of portfolio
275,303
Q3 2024 New
$442M
$13.2 Billion 3.96% of portfolio
1,554,586
Q3 2024 Reduced 29.7%
$3.01B
$10.9 Billion 3.27% of portfolio
213,815
Q3 2024 Reduced 61.2%
Biohaven LTD
-
$10.8 Billion 3.24% of portfolio
-
Q3 2024 Reduced 7.21%
Praxis Precision Medicines I
-
$10 Billion 3.0% of portfolio
-
Q3 2024 Added 494.81%
$258M
$9.5 Billion 2.84% of portfolio
2,616,602
Q3 2024 Reduced 1.73%
$16B
$8.56 Billion 2.56% of portfolio
129,490
Q3 2024 New
$3.31B
$8.22 Billion 2.46% of portfolio
282,050
Q3 2024 Added 12.37%
$1.01B
$7.06 Billion 2.11% of portfolio
506,978
Q3 2024 New
Acelyrin Inc
-
$6.5 Billion 1.95% of portfolio
-
Q3 2024 New
$60.3M
$6.03 Billion 1.81% of portfolio
1,278,444
Q3 2024 Added 8.52%
$578M
$5.13 Billion 1.54% of portfolio
449,735
Q3 2024 Reduced 10.45%
$1.39B
$5.05 Billion 1.51% of portfolio
86,930
Q3 2024 New
$3.86B
$5.02 Billion 1.5% of portfolio
60,076
Q3 2024 Reduced 78.6%
Vistagen Therapeutics Inc
-
$4.9 Billion 1.47% of portfolio
-
Q3 2024 Reduced 0.1%
$1.05B
$4.56 Billion 1.37% of portfolio
203,015
Q3 2024 Reduced 0.13%
$76.3M
$4.29 Billion 1.28% of portfolio
860,951
Q3 2024 Added 1.88%
Zura Bio LTD
-
$4.24 Billion 1.27% of portfolio
-
Q3 2024 New
$1.28B
$4.2 Billion 1.26% of portfolio
132,703
Q3 2024 Added 30.37%
$214M
$3.75 Billion 1.12% of portfolio
449,321
Q3 2024 New
Perspective Therapeutics Inc
-
$3.18 Billion 0.95% of portfolio
-
Q3 2024 Reduced 30.75%
$69.8M
$3.12 Billion 0.93% of portfolio
850,210
Q3 2024 Reduced 29.31%
Neurogene Inc
-
$3.08 Billion 0.92% of portfolio
-
Q3 2024 Reduced 6.75%
$263M
$3.07 Billion 0.92% of portfolio
241,984
Q3 2024 New
$85.7M
$2.53 Billion 0.76% of portfolio
743,719
Q3 2024 Reduced 0.09%
$1.25B
$2.46 Billion 0.74% of portfolio
300,000
Q3 2024 New
$3.47B
$2.42 Billion 0.72% of portfolio
94,885
Q3 2024 New
$1.94B
$2.24 Billion 0.67% of portfolio
49,415
Q3 2024 Reduced 46.84%
Surrozen Inc
-
$2.19 Billion 0.66% of portfolio
-
Q3 2024 Added 27.46%
$3.31B
$2.16 Billion 0.65% of portfolio
41,268
Q3 2024 New
Helix Acquisition Corp Ii
-
$2.09 Billion 0.63% of portfolio
-
Q1 2024 New
$10B
$1.88 Billion 0.56% of portfolio
15,014
Q3 2024 New
$25.8M
$1.73 Billion 0.52% of portfolio
942,857
Q3 2024 Reduced 4.19%
Perceptive Cap Solutions Cor
-
$1.5 Billion 0.45% of portfolio
-
Q2 2024 New
$440M
$1.42 Billion 0.43% of portfolio
93,638
Q3 2024 New
Tourmaline Bio Inc
-
$1.43 Billion 0.43% of portfolio
-
Q3 2024 New
$4.73B
$1.37 Billion 0.41% of portfolio
48,918
Q3 2024 New
$1.72B
$1.34 Billion 0.4% of portfolio
83,662
Q3 2024 New
Mbx Biosciences Inc
-
$1.3 Billion 0.39% of portfolio
-
Q3 2024 New
$4.62B
$764 Million 0.23% of portfolio
14,464
Q3 2024 New
$4.98B
$755 Million 0.23% of portfolio
16,654
Q3 2024 New
$143M
$619 Million 0.19% of portfolio
56,287
Q3 2024 New
$2.02B
$531 Million 0.16% of portfolio
19,900
Q3 2024 Reduced 92.66%

Summary

  • Portfolio
  • No. of Stocks 58
  • Current Value $334 Billion
  • Prior Value $340 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 21 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email